Kyverna Therapeutics Max Drawdown (5Y) Analysis

Kyverna Therapeutics, Inc. (KYTX)

7.13 +0.09 (+1.28%) USD | NASDAQ | Sep 18, 16:00

7.13 0.00 (0.00%) After-Hours: 20:00

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for KYTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Max Drawdown (5Y) Chart

Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to . Start Trial.

Date	Value

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks

Start Trial

Cartesian Therapeutics, Inc.	97.12%
Allogene Therapeutics, Inc.	98.24%
Beam Therapeutics, Inc.	89.12%
Arrowhead Pharmaceuticals, Inc.	88.96%
Oncolytics Biotech, Inc.	92.83%